+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Hypertension Drugs Markets in China

  • PDF Icon

    Report

  • 215 Pages
  • November 2023
  • Region: China
  • AMID Co
  • ID: 836809

China's demand for Hypertension Drugs will continue to grow at 12% by 2032

China's demand for Hypertension Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2012, 2017 and 2022) and long-term forecasts through 2027 and 2032 are presented. Major producers in China are profiled.

The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments’ industry bureaus, industry publications, and the in-house databases. Interviews are conducted with Chinese industry experts, university professors, and producers in China. Economic models and quantitative methods are applied in this report to project market demand and industry trends. Metric system is used and values are presented in either Yuan (RMB, current price) and/or US dollars.

This market research report provides hard-to-find market data and analyses. Today, China has the largest market in the world. Tremendous fast-growing markets for imports and business opportunities for companies around the world. If you want to expand your business or sell your products in China, this research report provides the insights and projections into Chinese markets necessary for you to do so.

Table of Contents

I. INTRODUCTION
  • Report Scope and Methodology
  • Executive Summary
II. BUSINESS ENVIRONMENT
  • Economic Outlook
  • Key Economic Indicators
  • Industrial Output
  • Population and Labor
  • Foreign Investment
  • Foreign Trade
  • Financial and Tax Regulations
  • Banking System and Regulations
  • Foreign Exchange
  • Taxes, Tariff and Custom Duties
III. HYPERTENSION DRUGS INDUSTRY ASSESSMENTS
  • Hypertension Drugs Industry Structure
  • Market Size
  • Market Growth Drivers
  • Hypertension Drugs Sales Volume
  • Major Producer Facility Locations
  • Major Producers’ Sales Volume and Market Share
  • Labor Cost
  • Potential Entrants
  • Major Distributors
  • Major Foreign Investment
  • Technology Development
IV. HYPERTENSION DRUGS PRODUCTION AND DEMAND
  • Market Overview by Drugs Classification
  • Calcium Channel Blocker
  • Felodipine
  • Nifedipine
  • Amlodipine
  • Nisoldipine
  • Nimodipine
  • Nitrendipine
  • Angiotensin ? Receptor Antagonists Drug
  • Losartan
  • Valsartan
  • Irbesartan
  • Telmisartan
  • Candesartan
  • Angiotensin-Converting Enzyme Inhibitor
  • Benazepril
  • Enalapril
  • Captopril
  • Lisinopril
  • Ramipril
  • Other Hypertension Drugs
  • Import and Export
  • Market Overview by Producers
  • Pricing Trend
V. HYPERTENSION DRUGS MARKET OUTLOOK
  • Hypertension Drugs Markets Outlook Overview
  • Government Regulation
  • Health Care Insurance Industry Overview
  • Consumer Spending Trends
  • Northeast
  • North
  • Southeast
  • Central
  • Southwest
  • Northwest
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds
VI. MARKETING STRATEGIES
  • China Market Entry Overview
  • China's Distribution System
  • Rubber Processing Chemicals Distribution Channels
  • Transportation and Freight Infrastructure
  • Communications
  • China’s Market Entry
  • Licensing
  • Franchising
  • E-commerce
  • Trading Companies and Local Agents
  • Representative Offices and Chinese Subsidiaries
  • Wholly Foreign Owned Enterprises
VII. HYPERTENSION DRUGS PRODUCER DIRECTORY
  • Profiles of Hypertension Drugs Producers and Major Consumption in Industry
LIST OF TABLES
I. INTRODUCTION
  • Economic Outlook Summary
II. BUSINESS ENVIRONMENT
  • Key Economic Indicators
  • Industrial Output
  • Population and Labor Force Trends
  • Foreign Investment and Loans
  • Foreign Trade
III. HYPERTENSION DRUGS INDUSTRY ASSESSMENTS
  • Calcium Channel Blocker Sales Volume and Market Share by Drugs Classification
  • Angiotensin ? Receptor Antagonists Drug Sales Volume and Market Share by Drugs Classification
  • Angiotensin-Converting Enzyme Inhibitor Sales Volume and Market Share by Drugs Classification
  • Other Hypertension Drugs Sales Volume and Market Share by Drugs Classification
  • Hypertension Drugs Sales Volume
  • Major Producer Facility Location
  • Major Hypertension Drugs Producer Sales Volume
  • Major Foreign Investment in China
IV. HYPERTENSION DRUGS PRODUCTION AND DEMAND
  • Hypertension Drugs Sales Volume by Drugs Classification
  • Calcium Channel Blocker Sales Volume and Market Share by Drugs Classification
  • Angiotensin ? Receptor Antagonists Drug Sales Volume and Market Share by Drugs Classification
  • Angiotensin-Converting Enzyme Inhibitor Sales Volume and Market Share by Drugs Classification
  • Other Hypertension Drugs Sales Volume and Market Share by Drugs Classification
  • Hypertension Drugs Import by Drugs Classification
  • Hypertension Drugs Export by Drugs Classification
  • Hypertension Drugs Major Producer, Sales Volume, and Market Share
V. HYPERTENSION DRUGS MARKET OUTLOOK
  • Consumer Spending Trends
  • The Structure of Per Capita Expenditure in the Northeast of China
  • The Structure of Per Capita Expenditure in the North of China
  • The Structure of Per Capita Expenditure in the Southeast of China
  • The Structure of Per Capita Expenditure in the Central of China
  • The Structure of Per Capita Expenditure in the Southwest of China
  • The Structure of Per Capita Expenditure in the Northwest of China
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds
LIST OF CHARTS
I. INTRODUCTION
  • Hypertension Drugs Sales Volume
II. BUSINESS ENVIRONMENT
  • China’s GDP and Growth Rate
  • Industrial Output by Ownership
  • China’s Imports and Exports
III. HYPERTENSION DRUGS INDUSTRY ASSESSMENTS
  • Total Hypertension Drugs Sales Volume
  • Hypertension Drugs Sales Volume by Drugs Classification
  • Calcium Channel Blocker Market Share by Drugs Classification
  • Angiotensin-Converting Enzyme Inhibitor Market Share by Drugs Classification
  • Angiotensin ? Receptor Antagonists Drug Market Share by Drugs Classification
  • Other Hypertension Drugs Market Share by Drugs Classification
  • Hypertension Drugs Sales Volume
IV. HYPERTENSION DRUGS PRODUCTION AND DEMAND
  • Hypertension Drugs Sales Volume
  • Hypertension Drugs Import
  • Hypertension Drugs Export
  • Hypertension Drugs Sales Volume by Drugs Classification
  • Calcium Channel Blocker Sales Volume and Market Share
  • Calcium Channel Blocker Market Share by Drugs Classification
  • Angiotensin ? Receptor Antagonists Drug Sales Volume and Market Share
  • Angiotensin ? Receptor Antagonists Drug Market Share by Drugs Classification
  • Angiotensin-Converting Enzyme Inhibitor Sales Volume and Market Share
  • Angiotensin-Converting Enzyme Inhibitor Market Share by Drugs Classification
  • Other Hypertension Drugs Sales Volume and Market Share
  • Other Hypertension Drugs Market Share by Drugs Classification
  • Hypertension Drugs Import by Drugs Classification
  • Calcium Channel Blocker Import and Market Share
  • Angiotensin ? Receptor Antagonists Drug Import and Market Share
  • Angiotensin-Converting Enzyme Inhibitor Import and Market Share
  • Other Hypertension Drugs Import and Market Share
  • Hypertension Drugs Export by Drugs Classification
  • Calcium Channel Blocker Export and Market Share
  • Angiotensin-Converting Enzyme Inhibitor Export and Market Share
  • Angiotensin ? Receptor Antagonists Drug Export and Market Share
  • Other Hypertension Drugs Export and Market Share
VI. MARKETING STRATEGIES
  • China’s Distribution Channel

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Pfizer (Dalian) Pharmaceutical Co., Ltd
  • Bristol-Mysers Squibb (Shanghai) Co., Ltd